{"id":"W1448065076","doi":"10.1182/blood.v122.21.498.498","title":"Phase 1b Study Of The MDM2 Antagonist RG7112 In Combination With 2 Doses/Schedules Of Cytarabine","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Cytarabine; Internal medicine; Rash; Phases of clinical research; Pharmacokinetics; Refractory (planetary science); Pharmacology; Gastroenterology; Clinical trial; Oncology; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001376018,0.001722323,0.00235877,0.0007991064,0.0005544102,0.0009009525,0.001049356,0.001583751,0.005133417],"category_scores_gemma":[0.0008265238,0.0008287576,0.0008133046,0.0004745541,0.0008911887,0.0008435285,0.0003714058,0.003465397,0.001136811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008251809,"about_ca_system_score_gemma":0.001702671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008380334,"about_ca_topic_score_gemma":0.001844692,"domain_scores_codex":[0.9994732,0.0002447783,0.00002272676,0.0001012288,0.00004661649,0.000111513],"domain_scores_gemma":[0.9994659,0.00007204376,0.00009560207,0.0000650642,0.00004072841,0.0002607442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5773786,0.2029927,0.003639628,0.0006360729,0.0006500274,0.0003139635,0.0003098396,0.003329827,0.1222466,0.0004209499,0.005606893,0.08247487],"study_design_scores_gemma":[0.345852,0.6381384,0.005108698,0.00002526868,0.0001716891,0.0002330367,0.00004097571,0.001026115,0.006885222,0.0002490196,0.002242883,0.00002682309],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896979,0.000964764,0.0008706446,0.0006956739,0.0001313207,0.00471707,0.001449974,0.0001595737,0.001313163],"genre_scores_gemma":[0.9779683,0.001396267,0.00388941,0.0009638668,0.0002798589,0.007404689,0.00282885,0.0000837257,0.005185051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005133417,"threshold_uncertainty_score":0.01717299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009994532846563625,"score_gpt":0.2519459987357455,"score_spread":0.2419514658891818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}